MTOR and breast cancer: Recent reports have demonstrated that the PI3K/Akt/mTOR pathway is frequently altered in human breast cancer, and both genetic and biochemical data suggest that aberrant activation of the PI3K/Akt/mTOR pathway contributes to breast cancer development and tumourigenesis [42].